A tumor cell growth inhibitor from Polygonium hypoleucum Ohwi

Life Sciences

Volumn 61, Issue 23, 1997, Pages 2335-2344

  Kuo, Yuh Chi ^a   Sun, Chang Ming ^a   Ou, Jun Chih ^a   Tsai, Wei Jern ^a  

^a NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

Antitumor agent; Emodin; Polygonum hypoleucum Ohwi

Indexed keywords

ANTHRAQUINONE DERIVATIVE; ANTINEOPLASTIC AGENT; EMODIN; EMODIN 1 O BETA D GLUCOSIDE; PHYSCION; PHYSCION 1 O BETA D GLUCOSIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL LINE; CELL STRAIN K 562; CELL VIABILITY; CHINESE MEDICINE; CONTROLLED STUDY; CYTOTOXICITY; DRUG IDENTIFICATION; DRUG ISOLATION; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; RAJI CELL; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE; TUMOR GROWTH; VERO CELL;

ANTHRAQUINONES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL DIVISION; EMODIN; HUMANS; PLANTS, MEDICINAL; TUMOR CELLS, CULTURED;

ANIMALIA; POLYGONIUM; POLYGONUM; POLYGONUM HYPOLEUCUM;

EID: 0030659848     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00937-5     Document Type: Article

References (24)

1. Y.C. KUO, J.C. OU, W.J. TSAI, C.L. WU and C.M. SUN, J. Chinese Med. 6 211-222 (1995).
2. M. INOUE, H. NISHMIURA, H.H. LI and J. MIZUTANI, J. Chem. Ecol. 18 1833-1840 (1992).
3. R.J. SYDISKIS, D.G. OWEN, J.L. LOHR, K.-H.A. ROSLER and R.N. BLOMSTER, Antimicrob. Agents and Ch. 35 2463-2466 (1991).
4. A.C. GHOSH, A. MANMADE and A.L. DEMAIN, Toxins from Penicillium islandicum Sopp, J.V. Rodricks, C.W. Hesseltine and M.A. Mehlman (Eds), 625-638, Academic Press, Chicago (1977).
5. H. ANK, I. KOLTHOUM, H. ZAHER and H. LAATSCH, Arch. Microbiol. 126 223-230 (1980).
6. D.O. ANDERSON, N.D. WEBER, S.G. WOOD, B.G. HUGHES, B.K. MURRAY and J.A. NORTH, Antiviral Res. 16 185-196 (1991).
7. D.L. BARNARD, J.H. HUFFMAN, J.L. MORRIS, S.G. WOOD, B.G. HUGHES and R. SIDEWELL, Antiviral Res. 17 63-77 (1992).
8. R.K. GOEL, G. DAS-GUPTA, S.N. RAM, V.B. PANDEY, Indian J. Exp. Biol. 299 230-232 (1991).
9. T. TANAKA, K. METORI, S. MINEO, H. MATSUMOTO and T. SATOH, Yakugaku Zasshi 110 688-692 (1990).
10. H.C. HUANG, S.H. CHU and P.D. CHAO, Eur. J. Pharmacol. 198 211-213 (1991).
11. H.C. HUANG, J.H. CHANG., S.F. TUNG, R.T. WU, M.L. FLOEGH. and S.H. CHU, Eur. J. Pharmacol. 211 359-364 (1992).
12. C.M. TENG, C.H. LIN, C.N. LIN, M.I. CHUNG and T.F. HUANG, Thromb.-Haemost. 70 1014-1018 (1993).
13. M.I. CHUNG, K.H. GAN, C.N. LIN, F.N. KO and C.M. TENG, J. Nat. Prod. 56 929-934 (1993).
14. T.C. CHAN, C.J. CHANG, N.M. KOONCHANOK and R.L. GEAHLEN, Biochem. Biophys. Res. Commun. 193 1152-1158 (1993).
15. T. FREW, G. POWIS, M. BERGGREN, R.T. ABRAHAM, C.L. ASHENDEL, L.H. ZALKOW, C. HUDSON, S. QAZIA, K.E. GRUSZECKA and R. MERRIMAN, Anticancer Res. 14 2425-2428 (1994).
16. H. JAYASURIYA, N.M. KOONCHANOK, R.L. GEAHLEN, J.L. MCLAUGHLIN and C.J. CHANG, J. Nat. Prod. 55 696-698 (1992).
17. F. ZHENG, Chung-Hua-I-Hsueh-Tsa-Chih 73 343-345 (1993).
18. C.M. SUN, W. Jr. SYU, Y.C. KUO and C.L. WU, Phytomedicine 3 277-279 (1996).
19. H.H. WANG, J. Ethnopharmacol. 40 111-116 (1993).
20. N. MIYOKAWA, H. SUZUKI, T. NIKANIDO and T. OHMOTO Yakugaku Zasshi 112 534-543 (1992).
21. H.C. HUANG, C.R. LEE, P.D. CHAO, C.C. CHEN and S.H. CHU, Eur. J. Pharmacol. 205 289-99 (1991).
22. Z.H. JIN, D.L. MA and X.Z. LIN, Chung-Kuo-Chung-His-I-Chieh-Ho-Tsa-Chih 14 429-431 (1994).
23. X.B. KONG, L. RUBIN, L.I. CHEN, G. CISZEWAKA, K.A. WATANABE, W.P. TONG, F.M. SIROTNAK and T.C. CHOU, Mol. Pharmacol. 41 237-244 (1992).
24. Y.C. KUO, C.Y. LIN, W.J. TSAI, C.L. WU and C.F. CHEN, Cancer Invest. 12 611-615 (1994).